Average Co-Inventor Count = 4.97
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (7 from 116 patents)
2. Abbvie S.a.r.l. (5 from 15 patents)
3. Other (4 from 832,912 patents)
4. Galapagos Sas (4 from 5 patents)
5. Hoechst Aktiengesellschaft (3 from 6,662 patents)
6. Genentech, Inc. (3 from 3,224 patents)
7. Aventis Pharma S.a. (1 from 377 patents)
8. Sanofi-A Ventis Deutschland Gmbh (1,832 patents)
9. Abbvie Overseas Sarl (5 patents)
10. Dart Therapeutics LLC (1 patent)
19 patents:
1. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
2. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
3. 10130622 - Compounds for treatment of cystic fibrosis
4. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
5. 9796711 - [object Object]
6. 8765766 - Pyrimidine derivatives which are antagonists of the vitronectin receptor
7. 8133896 - Pyrimidine derivatives which are antagonist of the vitronectin receptor
8. 7846932 - Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor
9. 7825119 - Pyrimidine derivatives which are antagonists of vitronectin receptor
10. 7763621 - Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
11. 7582640 - Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
12. 6867208 - Vitronectin receptor antagonists, their preparation and their use
13. 6838453 - Antagonist derivatives of the vitronectin receptor
14. 6482821 - Vitronectin receptor antagonists, their preparation and their use
15. 6387895 - Vitronectin receptor antagonists, their preparation and their use